Product information and disease descriptionPlace of product in therapyDisease description
Epidemiology
19 evidence topics · 14 sources
First-line recurrent or metastatic HPV-negative head and neck squamous cell carcinoma, in combination with pembrolizumab
Product information and disease descriptionPlace of product in therapyDisease description
19 evidence topics · 14 sources